secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2022-02-23T23:59:59+00:00
Accession:  0001213900-22-008887
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed board director Catherine Sazdanoff resigns; Janet Grove appointed as replacement
--------------------------------------------------------------------------------

- Catherine Sazdanoff resigned from Board effective Feb 11, 2022 due to personal reasons.
- Janet Grove appointed as director effective Feb 11, 2022 to fill vacancy; term expires at 2022 AGM.
- Grove to serve on Compensation and Nominating & Governance Committees.
- Grove receives $35K annual retainer, up to $15K for committee service, plus stock options for 14,000 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390022008887/0001213900-22-008887-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390022008887/ea156089-8k_inmedpharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-008887

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer